Have a feature idea you'd love to see implemented?
Let us know!
INVA Innoviva Inc
Price (delayed)
$19.06
Market cap
$1.19B
P/E Ratio
18.87
Dividend/share
N/A
EPS
$1.01
Enterprise value
$1.38B
Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.
Highlights
The gross profit is up by 24% YoY and by 8% from the previous quarter
The revenue has grown by 21% YoY and by 7% from the previous quarter
INVA's net income has dropped by 56% since the previous quarter but it is up by 30% year-on-year
The company's EPS has shrunk by 55% QoQ but it rose by 25% YoY
The stock's price to earnings (P/E) is 178% more than its 5-year quarterly average of 6.8 and 101% more than its last 4 quarters average of 9.4
Innoviva's quick ratio has plunged by 86% from the previous quarter and by 77% YoY
Key stats
What are the main financial stats of INVA
Market
Valuations
Earnings
Shares outstanding
62.6M
Market cap
$1.19B
Enterprise value
$1.38B
Price to earnings (P/E)
18.87
Price to book (P/B)
1.78
Price to sales (P/S)
3.38
EV/EBIT
14.19
EV/EBITDA
10.06
EV/Sales
3.91
Revenue
$352.75M
EBIT
$97.31M
EBITDA
$137.16M
Free cash flow
$162.38M
Per share
Balance sheet
Liquidity
EPS
$1.01
Free cash flow per share
$2.6
Book value per share
$10.69
Revenue per share
$5.64
TBVPS
$16.03
Total assets
$1.23B
Total liabilities
$563.07M
Debt
$447.82M
Equity
$668.54M
Working capital
$176.87M
Debt to equity
0.67
Current ratio
1.79
Quick ratio
1.57
Net debt/EBITDA
1.36
Margins
Efficiency
Dividend
EBITDA margin
38.9%
Gross margin
87.9%
Net margin
18.3%
Operating margin
44.6%
Return on assets
5.2%
Return on equity
9.5%
Return on invested capital
8.4%
Return on capital employed
9.7%
Return on sales
27.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INVA stock price
How has the Innoviva stock price performed over time
Intraday
-0.47%
1 week
-0.94%
1 month
-3.98%
1 year
41.92%
YTD
18.83%
QTD
-1.29%
Financial performance
How have Innoviva's revenue and profit performed over time
Revenue
$352.75M
Gross profit
$310.18M
Operating income
$157.45M
Net income
$64.59M
Gross margin
87.9%
Net margin
18.3%
INVA's operating income has soared by 68% YoY and by 19% QoQ
The net margin has plunged by 58% from the previous quarter but it has grown by 6% YoY
INVA's net income has dropped by 56% since the previous quarter but it is up by 30% year-on-year
The operating margin has increased by 39% YoY and by 12% from the previous quarter
Growth
What is Innoviva's growth rate over time
Valuation
What is Innoviva stock price valuation
P/E
18.87
P/B
1.78
P/S
3.38
EV/EBIT
14.19
EV/EBITDA
10.06
EV/Sales
3.91
The stock's price to earnings (P/E) is 178% more than its 5-year quarterly average of 6.8 and 101% more than its last 4 quarters average of 9.4
The company's EPS has shrunk by 55% QoQ but it rose by 25% YoY
The P/B is 23% below the 5-year quarterly average of 2.3 but 11% above the last 4 quarters average of 1.6
The equity has increased by 7% year-on-year
The revenue has grown by 21% YoY and by 7% from the previous quarter
The P/S is 2.4% higher than the 5-year quarterly average of 3.3 and 2.4% higher than the last 4 quarters average of 3.3
Efficiency
How efficient is Innoviva business performance
INVA's ROA has plunged by 56% from the previous quarter but it is up by 21% YoY
INVA's return on equity has dropped by 56% since the previous quarter but it is up by 10% year-on-year
The company's return on sales fell by 48% QoQ and by 6% YoY
The return on invested capital has declined by 42% since the previous quarter but it is up by 9% year-on-year
Dividends
What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INVA.
Financial health
How did Innoviva financials performed over time
The total assets is 119% greater than the total liabilities
Innoviva's quick ratio has plunged by 86% from the previous quarter and by 77% YoY
The company's current ratio has shrunk by 86% QoQ and by 79% YoY
The debt is 33% less than the equity
The equity has increased by 7% year-on-year
The debt to equity has declined by 6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.